doxacurium
Trade name: nuromax
Approved
Mar 7, 1991
Doxacurium chloride (formerly recognized as BW938U80 or BW A938U) is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia for endotracheal intubation or to facilitate mechanical ventilation. Unlike a number of other related skeletal muscle relaxants, it is rarely used adjunctively to facilitate endotracheal intubation. Doxacurium chloride is a mixture of three trans, trans stereoisomers, a dl pair [(1R,1'R ,2S,2'S ) and (1S,1'S ,2R,2'R )] and a meso form (1R,1'S,2S,2'R). NUROMAX binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors, such as neostigmine. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Timeline
Indications
Mechanism of action
Muscle-type nicotinic acetylcholine receptor antagonist
non-depolarizing
Approval history
- approvedMar 7, 1991
Chemistry & pharmacology
SMILES
COc1cc(CC2c3c(cc(OC)c(OC)c3OC)CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCc3cc(OC)c(OC)c(OC)c3C2Cc2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC- Mol. weight
- 1035.24 g/mol
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL1237123 ↗
- WikipediaDoxacurium chloride ↗
- NCATSP40015Y3WW ↗
- ChEMBLCHEMBL1237099 ↗
Also known as
- bw a938u
- bw-a938u
- bw-a938u
- bw-a938u
- bw-a938u
- bw-a 938u
- bw-a-938u
- bw-a938u dichloride
- bw-a938u dichloride
- doxacurium
- doxacurium
- doxacurium
- doxacurium
- doxacurium
- doxacurium
- doxacurium
- doxacurium
- doxacurium
- doxacurium chloride
- doxacurium chloride
- doxacurium chloride
- doxacurium chloride
- doxacurium chloride
- doxacurium chloride
- nuromax
- nuromax
- nuromax
- nuromax